Biomarkers That Predict Response to Immune Checkpoint Inhibitor Therapy
The Wistar Institute
New research finds biological processes that improve prediction of therapeutic performance
Melanoma
Biomarkers to Predict Patient Response to Immunotherapy Treatment for Melanoma
Wake Forest Baptist Medical Center
New study finds blood biomarkers that help indicate the effectiveness of immune checkpoint inhibitors
First Melanoma Test to Reliably Predict Risk of Cancer Spread
Newcastle University
New test developed as mechanism of skin cancer growth understood
Researchers Uncover Insights into How Moles Change into Melanoma
Huntsman Cancer Institute
Gene-Based Blood Test for Melanoma Spread Evaluates Treatment Progress
NYU Langone Health
The test monitors blood levels of DNA fragments released by dying tumor cells as an early indicator of treatment success
Sensitizing 'Cold' Melanomas to Immunotherapies
American Association for Cancer Research
Approximately 40 percent of melanomas lack sufficient infiltration of immune cells within the tumor and therefore have poor responses to immunotherapies
Missing BAP1 Gene Associated with Immunosuppressive Molecules in Uveal Melanoma
University of Turku
Study suggests implications for immunotherapy development
Cold Plasma Patch Could Make Immunotherapy More Effective for Treating Melanoma
University of California - Los Angeles
The patch significantly prolonged survival, inhibited growth of tumors in mice
Tertiary Lymphoid Structures Help Sustain an Immune-Responsive Tumor Microenvironment in Melanoma Patients
Catherine Crawford-Brown, MSc, MScComm
Study identifies tertiary lymphoid structures as a potential target for improving response to melanoma immunotherapy
Researchers Assess Melanoma Progression with a New Liquid Biopsy Technique
Spanish National Cancer Research Centre
Until now, there was no way to identify patients with an increased risk of recurrence.